Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Biodesix (BDSX) Revenue: 2019-2025

Historic Revenue for Biodesix (BDSX) over the last 6 years, with Sep 2025 value amounting to $21.8 million.

  • Biodesix's Revenue rose 19.93% to $21.8 million in Q3 2025 from the same period last year, while for Sep 2025 it was $80.2 million, marking a year-over-year increase of 22.29%. This contributed to the annual value of $71.3 million for FY2024, which is 45.30% up from last year.
  • Latest data reveals that Biodesix reported Revenue of $21.8 million as of Q3 2025, which was up 8.74% from $20.0 million recorded in Q2 2025.
  • In the past 5 years, Biodesix's Revenue registered a high of $28.9 million during Q1 2021, and its lowest value of $6.5 million during Q3 2021.
  • For the 3-year period, Biodesix's Revenue averaged around $16.4 million, with its median value being $17.9 million (2024).
  • Per our database at Business Quant, Biodesix's Revenue soared by 466.44% in 2021 and then crashed by 77.32% in 2022.
  • Biodesix's Revenue (Quarterly) stood at $7.2 million in 2021, then spiked by 32.99% to $9.6 million in 2022, then skyrocketed by 52.68% to $14.7 million in 2023, then soared by 39.28% to $20.4 million in 2024, then rose by 19.93% to $21.8 million in 2025.
  • Its last three reported values are $21.8 million in Q3 2025, $20.0 million for Q2 2025, and $18.0 million during Q1 2025.